Investigation of the antianemic activity of phyllanthus reticulatus poir. In 2,4-dinitrophenylhydrazine-induced anemic rats

Brazilian Journal of Pharmaceutical Sciences · Published 2025-01-01 · DOI 10.1590/s2175-97902025e24540

Authors being retrieved — see the publisher record. https://doi.org/10.1590/s2175-97902025e24540

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

Comparative safety profile of Metamizole, Viminol, and Tapentadol: a prospective observational study on adverse reactions · Brazilian Journal of Pharmaceutical Sciences · 2026 · Same journal
Synthesis and activity evaluation of new second-generation santacruzamate a analogs against breast cancer cells · Brazilian Journal of Pharmaceutical Sciences · 2025 · Same journal
Molecular docking and quantitative structure-activity relationships for a series of Trypanosoma cruzi dihydroorotate dehydrogenase inhibitors · Brazilian Journal of Pharmaceutical Sciences · 2025 · Same journal
Dry powder inhalation for sildenafil citrate: formulation and performance tests · Brazilian Journal of Pharmaceutical Sciences · 2026 · Same journal
Evaluation of the antihyperlipidemic activity of Dracaena trifasciata (Prain) Mabb. ethanolic extract in high-fat diet-induced hyperlipidemia in rats · Brazilian Journal of Pharmaceutical Sciences · 2026 · Same journal
Implementation of pharmaceutical care: Important aspects for a lasting service · Brazilian Journal of Pharmaceutical Sciences · 2025 · Same journal
Development of a new methodology for dissolving tablets containing diltiazem hydrochloride marketed in Brazil using design of experiment · Brazilian Journal of Pharmaceutical Sciences · 2026 · Same journal
Biological potential and chemical profile of Carapanauba (Aspidosperma excelsum benth) extracts · Brazilian Journal of Pharmaceutical Sciences · 2026 · Same journal
Enhancement of irinotecan oral bioavailability through quality by design approach in nanobubble formulation development · Brazilian Journal of Pharmaceutical Sciences · 2026 · Same journal
Orlistat, an anti-obesity drug, suppressed osteosarcoma progression and potentiated pd1ab immune checkpoint blockade therapy via upregulation of serpinf1 · Brazilian Journal of Pharmaceutical Sciences · 2025 · Same journal